Executive Summary
USAID/Zambia obligated $90,212,500 across one federal professional services contract to RIGHT TO CARE ZAMBIA LIMITED, representing 0% defense-related activity in the period. The dominant agency and sector theme is USAID international health funding for HIV prevention and treatment under the MECH program.
The highest-conviction signal is neutral (strength 2/10, materiality 1/10) due to the recipient's status as a foreign-owned nonprofit with limited public equity implications. $80,280,560 has already been outlayed of the $90.2M obligation, with a ceiling of $121,447,869 including options. Key watch item: option exercises to expand beyond current obligation levels through performance end date of June 23, 2028.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Federal Professional Services Contracts digest from April 10, 2026.
Investment Signals (1)
- RIGHT TO CARE ZAMBIA LIMITED $90.2M USAID award limited by nonprofit status (LOW)▲
$90,212,500 cost-plus award fee contract for HIV services provides ~$12.9M estimated annual revenue but has limited direct implications for public equity investors as recipient is a foreign-owned nonprofit. Full and open competition award shows no competitive moat for public markets.
Risk Flags (1)
- Competition [MEDIUM RISK]▼
RIGHT TO CARE ZAMBIA LIMITED's USAID contract performance ends June 23, 2028, exposing to potential re-compete after 7-year term.
Opportunities (1)
- ◆
Option exercises could expand RIGHT TO CARE ZAMBIA LIMITED's USAID MECH HIV services contract from $90.2M obligation to $121.4M ceiling.
Sector Themes (1)
- ◆
USAID/Zambia awarded $90,212,500 via full and open competition to RIGHT TO CARE ZAMBIA LIMITED for MECH program HIV prevention/treatment services (NAICS 541611, PSC R408), with $80.3M outlayed and performance to 2028.
Watch List (1)
- 👁
{"entity"=>"RIGHT TO CARE ZAMBIA LIMITED", "reason"=>"$90.2M USAID obligation with $80.3M outlayed; potential growth to $121.4M ceiling via options in international HIV services.", "trigger"=>"option exercise; performance end date June 23, 2028"}
Get daily alerts with 1 investment signals, 1 risk alerts, 1 opportunities and full AI analysis of all 1 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Federal Professional Services Contracts
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals
May 27, 2026
Big Pharma Approvals — May 27, 2026
Big Pharma Approvals